Open Access Highly Accessed Research article

Follow-up of phase I trial of adalimumab and rosiglitazone in FSGS: III. Report of the FONT study group

Alexandra Peyser, Nathaniel MacHardy, Freya Tarapore, Jacqueline MacHardy, Leslie Powell, Debbie S Gipson, Virginia Savin, Cynthia Pan, Theresa Kump, Suzanne Vento and Howard Trachtman*

BMC Nephrology 2010, 11:2  doi:10.1186/1471-2369-11-2

Article Metrics

4045
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 55 accesses
  • Last 365 days: 639 accesses
  • All time: 4045 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information